Early impairment of β-cell function and insulin sensitivity characterizes normotolerant Caucasian women with previous gestational diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 16, Issue 7, 2006, Pages 485-493

  Lencioni, Cristina ^a   Volpe, Laura ^a   Miccoli, Roberto ^a   Cuccuru, Ilaria ^a   Chatzianagnostou, Kyriazoula ^a   Ghio, Alessandra ^a   Benzi, Luca ^a   Bonadonna, Riccardo C ^b   Del Prato, Stefano ^a   Di Cianni, Graziano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Disposition index; Gestational diabetes; Glucose tolerance; Insulin secretion; Insulin sensitivity

Indexed keywords

INSULIN;

ADULT; ARTICLE; CAUCASIAN; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-SECRETING CELLS; PREGNANCY;

EID: 33749252004     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.07.010     Document Type: Article

References (44)

1. King H. Epidemiology of glucose intolerance and gestational diabetes in women of child- bearing age. Diabetes Care 21 Suppl. 2 (1998) B9-B13
2. Jovanovic L., and Pettitt D.J. Gestational diabetes. J Am Med Assoc 28 (2001) 2516-2519
3. Coustan D. Gestational diabetes. In: Harris M.I., Cowie C.C., Stern M.P., Boyko E.J., Reiber G.E., and Bennett P.H. (Eds). Diabetes in America. 2nd ed. (1995), US Govt. Printing Office, Washington DC 703-717
4. O'Sullivan J.B. Diabetes after GDM. Diabetes 40 Suppl. 2 (1991) 131-135
5. Buchanan T.A., and Catalano P.M. The pathogenesis of GDM: implications for diabetes after pregnancy. Diabetes Rev 4 (1995) 584-601
6. Kjos S.L., and Buchanan T.A. Gestational diabetes mellitus. N Eng J Med 23 (1999) 1749-1756
7. Buchanan T.A. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86 (2001) 989-993
8. Mauricio D., and de Leiva A. Autoimmune gestational diabetes mellitus: a distinct clinical entity?. Diabetes Metab Res Rev 6 (2001) 422-428
9. Ben-Haroush A., Yogev Y., and Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabetes Med 21 (2004) 103-113
10. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25 (2002) 1862-1868
11. Catalano P.M., Tyzbir E.D., Roman N.M., Amini S.B., and Sims F.A. Longitudinal chanches in insulin release and insulin resistance in non obese pregnant women. Am J Obstet Gynecol 165 (1991) 1667-1672
12. Catalano P.M., Huston L., Amini S.B., and Kalhan S.C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180 (1999) 903-916
13. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 21 Suppl. 2 (1998) B19-B26
14. Catalano P.M., Tyzbir E.D., Wolfe R.R., Calles J., Roman N.M., Amini S.B., et al. Carbohydrate metabolism during pregnancy in control subject and women with gestational diabetes. Am J Physiol 264 (1993) E60-E67
15. Homko C., Sivan E., Chen X., Reece E.A., and Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Met 86 (2001) 568-573
16. Efendic S., Hanson U., Persson B., Wajngot A., and Luft R. Glucose tolerance, insulin release, and insulin sensitivity in normal weight women with previous gestational diabetes mellitus. Diabetes 36 (1987) 413-419
17. Donrhost A., Edwards S.G., Nicholls J.S., Anyaoku V., McLaren D., Heslop K.E., et al. A defect in insulin release in women at risk of future non-insulin-dependent diabetes. Clin Sci 81 (1991) 195-199
18. Ward W.K., Johnston C.L.W., Beard J.C., Benedetti T.J., Halter J.B., and Porte Jr. D. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes. Diabetes 34 (1985) 861-869
19. Kautzky-Willer A., Prager R., Waldhausl W., Pacini G., Thomaseth K., Wagner O.F., et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20 (1997) 1717-1723
20. Kousta E., Lawrence N., Godsland I.F., Penny A., Anyaoku V., Millauer B.A., et al. Insulin resistance and β-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clinical Endocrinology 59 (2003) 289-297
21. Kirvan J.P., Huston-Presley L., Kalhan S.C., and Catalano M. Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care 24 (2001) 1602-1607
22. Ryan E.A., Imes S.H., Liu D., Mc Manus R., Finegood D.T., Polonsky K.S., et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44 (1995) 506-512
23. Cretti A., Lethovirta M., Bonora E., Brunato B., Zenti M.G., Caputo M., et al. Assessment of β-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Inv 31 (2001) 405-416
24. Bonadonna R.C., Stumvoll M., Fritsche A., Muggeo M., Haring H., Bonora E., et al. Altered homeostatic adaptation of first- and second-phase β-cell secretion in the offspring of patients with type 2 diabetes. Diabetes 52 (2003) 470-480
25. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Assessment Insulin Secretion from the oral glucose tolerance test in with patients with type 2 diabetes. Diabetes Care 23 (2000) 1440-1441
26. Stumvoll M., Van Haeften T., Fritsche A., and Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24 (2001) 796-799
27. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
28. Matsuda M., and DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 22 (1999) 1462-1470
29. Carpenter M.W., and Coustan D.R. Criteria for screening test for gestational diabetes. Am J Obstet Gynecol 144 (1982) 763-773
30. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
31. Khan S.E., Prigeon R.L., Mcculloch D.K., Boyko E.J., Bergman R.N., Schwartz W., et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes 42 (1993) 1663-1672
32. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implication. Diabetes 44 (1995) 863-870
33. Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 7 (2001) 44-51
34. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
35. Lupi R., Dotta F., Marselli L., Del Guerra S., Masini M., Santangelo C., et al. Prolonged exposure to free fatty acids as cytostatic and pro-apoptotic effects on human pancreatic islets. Diabetes 51 (2002) 1437-1442
36. Catalano P.M., Bernstein I.M., Wolfe R.R., Srikanta S., Tybzir E., and Sims E.A. Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. Am J Obstet Gynecol 155 (1986) 1255-1263
37. Weyer C., Tarantini A., Bogardus C., and Pratley R. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24 (2000) 89-94
38. Bergam R.N., Ader M., Huecking K., and Van Citters G. Accurate assessment of β-cell function. Diabetes 51 Suppl. 1 (2002) S212-S220
39. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 18 (2001) 1343-1350
40. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 6 (2002) 393-403
41. Parillo M., and Riccardi G. Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. Br J Nutr 1 (2004) 7-19
42. Bray G.A. Medical consequences of obesity. J Clin Endocrinol Metab 89 (2004) 2583-2589
43. O'Sullivan J.B. Body weight and subsequent diabetes mellitus. JAMA 248 (1982) 949-952
44. Metzger B.E., Roston S.M., Cho N.H., and Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 16 (1993) 1598-1605